The role of dopaminergic medication and specific pathway alterations in idiopathic and PRKN/PINK1- -mediated Parkinson’s disease

Author(s):
Balck, A.; Borsche, M.; Campbell, P.; Luo, X.; Harvey, J.; Brückmann, T.; Ludwig, C.; Harms, A.C.; Lohmann, K.; Brown, E.; Morris, H.R.; Schapira, A.H.; Hankemeier, T.; Fleming, R.M.; Szymczak, S.; Klein, C.
Published
2025
Publication type
Article / Letter to editor
Date issued
2025-05-14
Language
English
Is part of
Science Advances (2025), No. 20, eadp7063
hdl
1887/4252291
doi
10.1126/sciadv.adp7063